BASIS OF PRESENTATION, MEASUREMENT AND CONSOLIDATION (Details Narrative) - USD ($)				3 Months Ended	6 Months Ended	12 Months Ended
	Sep. 19, 2023	Jul. 19, 2023	Jun. 29, 2023	Mar. 31, 2024	Sep. 30, 2021	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2022	Mar. 31, 2021
Stockholders equity reverse stock split						the Company’s 1:6 Reverse Split
Accumulated deficit				$ 127,499,785		$ 127,499,785	$ 112,570,825
Working capital deficiency				$ 18,228,253		18,228,253
Proceeds from issuance of debt									$ 11,756,563
Proceeds from issuance initial public offering					$ 14,545,805
Proceeds from short term debt						853,030	1,476,121
Debt conversion converted instrument amount						$ 2,962,386	2,355,318
Conversion of convertible securities						36,897
Gross proceeds from issuance of common stock						$ 123,347
Proceeds from Issuance of Common Stock						$ 119,285
Placement fee percentage						3.00%
Preferred stock, par value				$ 0.001		$ 0.001	$ 0.001
Net proceeds issuance costs						$ 2,825,000
Stock issued during period, value						$ 119,285
Series B Preferred Stock [Member]
Preferred stock, shares issued	220			180		180
Preferred stock, par value	$ 0.001			$ 0.001		$ 0.001	$ 0.001
Preferred stock convertible purchase price	$ 9,091
Gross proceeds	$ 2,000,000
Net proceeds issuance costs	$ 1,900,000			$ 925,000
Economic Injury Disaster Loan [Member]
Proceeds from issuance of debt								$ 499,900
Common Stock [Member]
Stockholders equity reverse stock split			one-for-six (1-for-6) share consolidation (the “Reverse Split”)
Issuance of common shares to adjust for rounding effect of reverse split, shares		20,846				20,846
Stock issued during period						36,897
Stock issued during period, value						$ 37
Preferred Stock [Member]
Stock issued during period, value
Preferred Stock [Member] | Series B Preferred Stock [Member]
Stock issued during period				110
Stock issued during period, value				$ 925,000